Viracta Therapeutics
Precision oncology company developing targeted therapies for virus-associated cancers, including EBV-positive lymphomas. Publicly traded on NASDAQ (VIRX).
Website
https://www.viracta.comLocation
San Diego, California, USA
Founded
2016
Investors
1
Categories
biotech, oncology, precision-medicine, virus-associated-cancer, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| aMoon | Tel Aviv, Israel | biotech-focused | series-aseries-b+2 | 8 |
